Oracle Analysts Slash Target by $107 as Shares Plunge Over 50%
Oracle’s shares have slumped over 50% year-to-date as AI data-center cost overruns and a heavy debt load prompted Morgan Stanley to cut its price target by $107 to $213. Bulls like Guggenheim still project up to $400, citing Oracle’s BYOC AI infrastructure model and cash-flow potential.
1. Principal Financial Group Boosts Position in Oracle
During the third quarter, Principal Financial Group increased its stake in Oracle by 7.6%, acquiring an additional 172,624 shares to bring its total to 2,441,969 shares. According to the latest SEC filing, this position represents approximately 0.09% of Oracle’s outstanding stock and was valued at just under 687 million dollars at the end of the period. This incremental purchase underscores Principal’s confidence in Oracle’s enterprise software and cloud infrastructure growth prospects.
2. Major Institutions Adjust Holdings
Several of the world’s largest asset managers have recently fine-tuned their Oracle positions. Vanguard expanded its stake by 2.1%, adding over 3.35 million shares to reach 164.28 million shares, while State Street increased its holdings by 1.7%, acquiring 1.25 million additional shares for a total of 73.46 million shares. Norges Bank established a new position in Oracle valued at more than 4.27 billion dollars, reflecting sovereign wealth interest in the software giant. Collectively, such moves demonstrate broad institutional conviction, with nearly 42.5% of shares now held by hedge funds and mutual funds.
3. Analyst Consensus Remains Positive
Wall Street research desks continue to view Oracle favorably. Recent reports include an equal-weight rating with an elevated target from Stephens, and outperform endorsements from Sanford C. Bernstein and William Blair. While some firms trimmed objectives—Morgan Stanley notably lowered its projection—three analysts maintain a strong buy outlook, twenty-five a buy rating, eleven a hold, and only two a sell. The aggregated average target price stands in the low three-hundreds range, reinforcing the market’s moderate-buy consensus on Oracle’s long-term earnings and cash-flow trajectory.